bluebird bio, Inc. (BLUE) has a market capitalization of $48.67M and trades at $4.97. The 52-week range is 3.2-28.6.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-24.84, annual revenue of $83.81M.
The stock has a beta of 0.37, operates in the Healthcare sector.
